Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.87 -3.77%
EPS Growth %: -30.4%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -30.4%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of ($0.11), $0.09 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $28.3 million versus the consensus estimate of $28.84 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- BIG3 Basketball to go public via Graf Global merger at $290 million
- Schwab's May activity shows margin loans nearly double
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
